Pages that link to "Q67899001"

The following pages link to Responses to NMDA receptor antagonists altered by epileptogenesis (Q67899001):

Displaying 28 items.

• Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy (Q24674705) (← links)
• Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma (Q27693823) (← links)
• Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs (Q34162438) (← links)
• Neuropsychotoxic and Neuroprotective Potentials of Dextromethorphan and Its Analogs (Q34186904) (← links)
• Current status and future directions in the pharmacotherapy of epilepsy (Q34552599) (← links)
• New horizons in the development of antiepileptic drugs (Q34768775) (← links)
• Use of epileptic animals for adverse effect testing (Q34768794) (← links)
• Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy (Q34768821) (← links)
• LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. (Q35028128) (← links)
• Neuropsychopharmacological understanding for therapeutic application of morphinans (Q36102944) (← links)
• The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential. (Q36675813) (← links)
• Discovery of antiepileptic drugs (Q36697466) (← links)
• New avenues for anti-epileptic drug discovery and development (Q38139837) (← links)
• Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs (Q38746272) (← links)
• Antagonists of the NMDA receptor-channel complex and motor coordination (Q40464863) (← links)
• Animal models of intractable epilepsy (Q40878126) (← links)
• New visions in the pharmacology of anticonvulsion (Q41739650) (← links)
• Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy (Q41749968) (← links)
• Kindling Increases the Sensitivity of Rats to Adverse Effects of Certain Antiepileptic Drugs (Q42277354) (← links)
• Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models (Q42857144) (← links)
• Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling (Q48098170) (← links)
• Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats (Q48151790) (← links)
• Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats (Q48226383) (← links)
• Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats (Q48401319) (← links)
• Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats (Q48403488) (← links)
• Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats (Q48520570) (← links)
• The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach? (Q48581800) (← links)
• Behavioral effects of NBQX, a competitive antagonist of the AMPA receptors. (Q52039466) (← links)